M. Ouali
Impact in
-
- Sarcoma Diagnosis and Treatment
- Renal cell carcinoma treatment
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
Papers in
-
- Sarcoma Diagnosis and Treatment 14
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Pancras C.W. Hogendoorn (8 shared papers)Jean‐Yves Blay (12 shared papers)Peter Hohenberger (13 shared papers)Sandrine Marréaud (9 shared papers)M. van Glabbeke (8 shared papers)Jaap Verweij (3 shared papers)Axel Le Cesne (8 shared papers)Axel Le Cesne (3 shared papers)
In The Last Decade
M. Ouali
40 papers receiving 1.8k citations
M. Ouali's Hit Papers
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 618
- Rheumatology 270
- Pathology and Forensic Medicine 244
- Neurology 201
Countries citing papers authored by M. Ouali
This map shows the geographic impact of M. Ouali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ouali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ouali more than expected).
Fields of papers citing papers by M. Ouali
This network shows the impact of papers produced by M. Ouali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ouali. The network helps show where M. Ouali may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Ouali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial Hit paper breakdown → | 2012 | 389 |
| 2 | 2009 | 199 | |
| 3 | 2011 | 175 | |
| 4 | 2010 | 161 | |
| 5 | 2015 | 124 | |
| 6 | 2014 | 119 | |
| 7 | 2013 | 105 | |
| 8 | 2014 | 67 | |
| 9 | 2010 | 63 | |
| 10 | 2014 | 59 | |
| 11 | 2012 | 41 | |
| 12 | 2015 | 37 | |
| 13 | 2012 | 35 | |
| 14 | 2013 | 30 | |
| 15 | [Hydatid cyst of the pancreas. Apropos of 7 cases]. | 1994 | 30 |
| 16 | 2011 | 29 | |
| 17 | 2011 | 28 | |
| 18 | 2014 | 19 | |
| 19 | [Primary renal non Hodgkin's lymphoma]. | 2004 | 19 |
| 20 | 2016 | 17 |
About M. Ouali
M. Ouali is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Rheumatology and Surgery, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Melanoma and MAPK Pathways (2 papers), Soft tissue tumor case studies (2 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (618 citations), Rheumatology (270 citations), Pathology and Forensic Medicine (244 citations) and Neurology (201 citations). M. Ouali has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Pancras C.W. Hogendoorn, Jean‐Yves Blay, Peter Hohenberger, Sandrine Marréaud, M. van Glabbeke, Jaap Verweij, Axel Le Cesne, Axel Le Cesne, Michael Leahy and Sylvie Bonvalot. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Journal of Nuclear Cardiology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.